Concepedia

Author

Danielle Carroll

AstraZeneca (United Kingdom)

Also Known As

D. Carroll, Danielle Carroll, Danielle K. Carroll

66

Publications

1.9K

Citations

20

H-Index

86

Concepts

All Affiliations

AstraZeneca (United Kingdom)AstraZeneca (United States)Vall d'Hebron Hospital UniversitariSarah CannonThe Christie NHS Foundation Trust
DC

About

Danielle Carroll is an author at AstraZeneca (United Kingdom) specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

13

1.3K

2

Engineering

4

4

136

3

Health Sciences

2

2

52

4

Natural Sciences

1

1

13

5

Biomedical Engineering

1

1

39

Danielle Carroll

×

24

Publications

1.8K

Citations

20

H-Index

YearCitations

Regulation of In Situ to Invasive Breast Carcinoma Transition

Min Hu, Jun Yao, Danielle Carroll,

Cancer Cell

2008

501

p63 regulates an adhesion programme and cell survival in epithelial cells

Danielle Carroll, Jason S. Carroll, Chee‐Onn Leong,

Nature Cell Biology

2006

394

An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer

Thomas Powles, Danielle Carroll, Simon Chowdhury,

Nature Medicine

2021

108

Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy

Xing Cheng, Weijia Wang, Qi Xu,

Journal of Virology

2016

80

Determining suitable internal standards for mRNA quantification of increasing cancer progression in human breast cells by real-time reverse transcriptase polymerase chain reaction

David L. Morse, Danielle Carroll, Lyndon Weberg,

Analytical Biochemistry

2005

77

Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro

Shannon Burke, Amy L. Shergold, Matthew J. Elder,

Cancer Immunology Immunotherapy

2020

71

Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)

Alan L. Ho, Marek Dedecjus, Lori J. Wirth,

Journal of Clinical Oncology

2022

59

PL02.11 Normalized Membrane Ratio of TROP2 by Quantitative Continuous Scoring is Predictive of Clinical Outcomes in TROPION-Lung 01

M.C. Garassino, J. Sands, Luis Paz‐Ares,

Journal of Thoracic Oncology

2024

49

A Randomized, Open-label, Presurgical, Window-of-Opportunity Study Comparing the Pharmacodynamic Effects of the Novel Oral SERD AZD9496 with Fulvestrant in Patients with Newly Diagnosed ER+ HER2− Primary Breast Cancer

J.F.R. Robertson, Abigail Evans, Stephan Henschen,

Clinical Cancer Research

2020

48

Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway

David L. Morse, Danielle Carroll, Sam E. Day,

NMR in Biomedicine

2008

45

Page 1